Update on the Use of Anti-VEGF Drugs in the Treatment of Retinopathy of Prematurity.

Overview of attention for article published in Journal of Pediatric Ophthalmology and Strabismus, November 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 3,452 followers.

#JPOS authors Seery et al determine whether "intravitreal #anti-VEGF therapy [is] effective in preventing retinal neovascularization in infants with #ROP." https://t.co/siIpT7HAE5 https://t.co/cZoLDv1OlV

#ReviewArticle Update on the Use of Anti-VEGF Drugs in the Treatment of Retinopathy of Prematurity https://t.co/mZADCimUvi https://t.co/3IUjy0z08O

RT @JPOSJournal: Seery et al's #ReviewArticle "focuses on the ophthalmic and systemic benefits and risks of anti-VEGF therapies for #ROP as…

Seery et al's #ReviewArticle "focuses on the ophthalmic and systemic benefits and risks of anti-VEGF therapies for #ROP as compared to retinal photocoagulation" https://t.co/Ra9eVm1SjW https://t.co/4bPtqwMQMT

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.